Subtilase variants
US-11952558-B2 · Apr 9, 2024 · US
US12529016B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12529016-B2 |
| Application number | US-202318401382-A |
| Country | US |
| Kind code | B2 |
| Filing date | Dec 30, 2023 |
| Priority date | Dec 15, 2014 |
| Publication date | Jan 20, 2026 |
| Grant date | Jan 20, 2026 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention relates to novel protease variants exhibiting improved stability and or improved wash performance in liquid detergent. The variants of the invention are suitable for use in e.g. cleaning or detergent compositions, such as laundry detergent compositions and dish wash compositions, including automatic dish wash compositions. The present invention also relates to isolated DNA sequences encoding the variants, expression vectors, host cells, and methods for producing and using the variants of the invention.
Opening claim text (preview).
The invention claimed is: 1 . A subtilase variant having at least 90% sequence identity to SEQ ID NO: 3 wherein the variant has a glutamic acid residue (E) in position 101, wherein the subtilase variant further comprises one or more substitutions selected from the group consisting of S156D, L262E, S3T, and Y209W, wherein the variant has increased stability in a liquid detergent composition compared to the subtilase having the amino acid sequence of SEQ ID NO: 3 and wherein the positions correspond to the positions of SEQ ID NO: 1. 2 . The subtilase variant of claim 1 , wherein the subtilase further has improved wash performance compared with the subtilase having SEQ ID NO: 3. 3 . The subtilase variant of claim 1 , wherein the subtilase further has improved stability compared with the subtilase having SEQ ID NO: 3. 4 . The subtilase variant of claim 1 , wherein the subtilase variant further comprises one or more substitutions selected from the group consisting of: R45E,D,Q; T58L; G61D; S87E; G97S; A98E; S160A; N117E; H120D,K,V; P129D; E136Q; Q137H; S161T; S163A,G; V199M; M222Q; and N261T. 5 . The subtilase variant of claim 1 , wherein the variant is selected from the group consisting of: SEQ ID NO: 3+S3T, SEQ ID NO: 3+Y209W, SEQ ID NO: 3+L262N,Q,D,E SEQ ID NO: 3+S156D+L262E SEQ ID NO: 3+N238E+L262E SEQ ID NO: 3+S3T+N76D+S156D+Y209W SEQ ID NO: 3+S163G+N128Q+N238E+L262E SEQ ID NO: 3+V104T+H120D+S156D+L262E SEQ ID NO: 3+S3T+V41+N261D SEQ ID NO: 3+S3T+V41+A228V SEQ ID NO: 3+N76D+A228V+L262E SEQ ID NO: 3+Q137H+S141H+R145H+N238E+L262E SEQ ID NO: 3+S3T+N76D+Q137H+S141H+R145H+S156D+Y209W SEQ ID NO: 3+S3T+Q59D+N76D SEQ ID NO: 3+S3T+N76D+H120D SEQ ID NO: 3+S3T+N76D+A194P+G195E+V199M+V2051 SEQ ID NO: 3+S3T+N76D+S156D SEQ ID NO: 3+S3T+N76D+Y209W+N261D SEQ ID NO: 3+S3T+N76D+H120D+Y209W SEQ ID NO: 3+S3T+N76D+S156D+Y209W SEQ ID NO: 3+S3T+V41+N76D+A228V+N261D SEQ ID NO: 3+S3T+V41+N76D+H120D SEQ ID NO: 3+N76D+A228V+L262E SEQ ID NO: 3+N261D+L262E SEQ ID NO: 3+S87E+L262E SEQ ID NO: 3+Q59D+L262E SEQ ID NO: 3+K27Q+L262E SEQ ID NO: 3+H120D+L262E SEQ ID NO: 3+K27Q+S156D SEQ ID NO: 3+H120D+S163G+L262E SEQ ID NO: 3+S3T+N76D SEQ ID NO: 3+S3T+H120D SEQ ID NO: 3+S3T+S163G SEQ ID NO: 3+S156D+S163G SEQ ID NO: 3+S3T+T58L SEQ ID NO: 3+T58L+S156D SEQ ID NO: 3+S3T+N76D+H120D SEQ ID NO: 3+S3T+N76D+A228V SEQ ID NO: 3+S3T+N76D+S156D SEQ ID NO: 3+S3T+N76D+Y209W SEQ ID NO: 3+S3T+N76D+Y209W+V244T SEQ ID NO: 3+N76D+S156D SEQ ID NO: 3+H120D+S156D SEQ ID NO 3+R45E+L262E SEQ ID NO 3+S87E+L262E SEQ ID NO 3+G61D+L262E SEQ ID NO 3+Q59D+L262E SEQ ID NO 3+Q59D+S156D SEQ ID NO 3+S156D+L262E SEQ ID NO 3+S163G+N238E+L262E SEQ ID NO 3+S3T+V41+S163G+N261D SEQ ID NO 3+S3T+V41+S163G+N261D SEQ ID NO 3+S87E+S163G+L262E SEQ ID NO 3+S156D+S163G+L262E SEQ ID NO 3+T58L+S163G+N261D SEQ ID NO 3+S156D+S163G+L262E and SEQ ID NO 3+S3T+N76D+Y209W+N261D+L262E. 6 . A nucleotide sequence encoding a variant according to claim 1 . 7 . An expression vector comprising the nucleotide sequence of claim 6 . 8 . A recombinant host cell comprising the nucleotide sequence of claim 6 or the expression vector of claim 7 . 9 . A method for producing the variant according to claim 1 , comprising: Providing a recombinant host cell comprising a nucleotide sequence encoding a subtilase variant having at least 90% sequence identity to SEQ ID NO: 3 wherein the variant has a glutamic acid residue (E) in position 101, wherein the subtilase variant further comprises one or more substitutions selected from the group consisting of S156D, L262E, S3T, and Y209W, wherein the variant has increased stability in a liquid detergent composition compared to the subtilase having the amino acid sequence of SEQ ID NO: 3 and wherein the positions correspond to the positions of SEQ ID NO: 1; Culturing the recombinant host cell under conditions leading to expression of the variant; and Isolating the variant. 10 . The variant of claim 1 , wherein the variant has at least 95% sequence identity to SEQ ID NO: 3. 11 . The variant of claim 1 , wherein the variant has at least 96% sequence identity to SEQ ID NO: 3. 12 . The variant of claim 1 , wherein the variant has at least 97% sequence identity to SEQ ID NO: 3. 13 . The variant of claim 1 , wherein the variant has at least 98% sequence identity to SEQ ID NO: 3. 14 . The variant of claim 1 , wherein the subtilase variant further comprises two or more substitutions selected from the group consisting of S156D, L262E, Q137H, S3T, R45E,D,Q, P55N, T58W,Y,L, Q59D,M,N,T, G61D,R, S87E, G97S, A98D,E,R, S106A,W, N117E, H120V,D,K,N, S124M, P129D, E136Q, S143W, S161T, S163A,G, Y171L, A172S, N185Q, V199M, Y209W, M222Q, N238H, V244T, N261T,D and L262N,Q,D. 15 . The variant of claim 1 , wherein the subtilase variant further comprises three or more substitutions selected from the group consisting of S156D, L262E, Q137H, S3T, R45E,D,Q, P55N, T58W,Y,L, Q59D,M,N,T, G61D,R, S87E, G97S, A98D,E,R, S106A,W, N117E, H120V,D,K,N, S124M, P129D, E136Q, S143W, S161T, S163A,G, Y171L, A172S, N185Q, V199M, Y209W, M222Q, N238H, V244T, N261T,D and L262N,Q,D.
Site-1 protease (3.4.21.112), i.e. subtilisin kexin isozyme-1 · CPC title
bacteria being Bacillus · CPC title
Protease or amylase in liquid compositions only · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.